<DOC>
	<DOCNO>NCT01537055</DOCNO>
	<brief_summary>To compare efficacy tolerability levofloxacin-based sequential therapy triple therapy second line therapy fail one eradication therapy</brief_summary>
	<brief_title>Comparison Efficacy Levofloxacin-based Sequential Therapy Triple Therapy Second Line Therapy</brief_title>
	<detailed_description>About 600 patient fail first line triple therapy sequential therapy eligible multicenter randomize comparative trial . Eligible patient randomize receive either ( 1 ) levofloxacin-based sequential therapy 10 days〔lansoprazole 30mg amoxicillin 1g first 5 day , follow lansoprazole 30mg , levofloxacin 250mg , metronidazole 500mg another 5 day ( give twice daily ) 〕or ( 2 ) levofloxacin-based triple therapy 10 days〔lansoprazole 30mg amoxicillin 1g , levofloxacin 250mg 10 day ( give twice daily ) 〕 . Eradication confirm 13C-Urea Breath Test 6 week therapy .</detailed_description>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>H. pylorus infect patient fail first line therapy eligible study Patients exclude study one follow criterion present : child teenager age less 20 year , history gastrectomy , gastric malignancy , include adenocarcinoma lymphoma , previous allergic reaction antibiotic ( amoxicillin , metronidazole , levofloxacin ) PPI ( lansoprazole ) , contraindication treatment drug , pregnant lactate woman , severe concurrent disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>H pylori eradication</keyword>
</DOC>